Insmed, Inc. (INSM)
195.26
+5.41
(+2.85%)
USD |
NASDAQ |
Dec 11, 16:00
197.00
+1.74
(+0.89%)
After-Hours: 20:00
Insmed Free Cash Flow: -906.14M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc. | 10.38B |
| United Therapeutics Corp. | 1.116B |
| Alnylam Pharmaceuticals, Inc. | 221.36M |
| Madrigal Pharmaceuticals, Inc. | -164.63M |
| Vertex Pharmaceuticals, Inc. | 3.337B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -219.76M |
| Cash from Investing (Quarterly) | -762.23M |
| Cash from Financing (Quarterly) | 33.41M |
| Free Cash Flow Per Share (Quarterly) | -1.049 |
| Free Cash Flow to Equity (Quarterly) | -223.92M |
| Free Cash Flow to Firm (Quarterly) | -201.72M |
| Free Cash Flow Yield | -2.44% |